Proteomics International
Proteomics International is a pioneering medical technology company.
Raised 2.04M EQUITY on November 15, 2019
About
Proteomics International develops the PromarkerD proteomic diagnostic and pursues licensing and partnering opportunities to commercialize the test.
Mission
Proteomics International announced a capital raising of A$3.0 million via a heavily oversubscribed placement. The company described the placement as successful and heavily oversubscribed. Management said the proceeds leave Proteomics well-funded into CY20 and beyond. The raise strengthens the company's balance sheet. Company statements say the stronger balance sheet is intended to support any potential future licensing or partnering discussions around PromarkerD.
Quick Facts
Founded
2001
Funding
EQUITY
Industry
Biotechnology
Team Size
11-50
Headquarters
Perth, Western Australia, Australia
Careers
View Careers Page
Proteomics International
https://jobs.ashbyhq.com/proteomicsNo open roles at this time.
Check their careers page for updates